Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among U.S. adults

Pharmacoepidemiology and Drug Safety
Ryne Paulose-RamQiuping Gu

Abstract

Analgesics offer many benefits, however, chronic, long-term use may pose risks of adverse drug events. The objective of this study was to estimate frequent monthly non-narcotic analgesic use among U.S. adults, identifying socio-demographic trends and potentially at-risk groups. Analysis of adult medication use data from the 1999-2000 National Health and Nutrition Examination Survey household interview (n = 4880). Some 20% of U.S. adults used non-prescription or prescription non-narcotic analgesics on a frequent basis, that is nearly every day for a month, at some point during their lifetime. Also, 14% of U.S. adults were currently using analgesics frequently. Aspirin was most commonly used (8%), followed by non-aspirin non-steroidal anti-inflammatory drugs (NANSAID, 3%) and acetaminophen (3%). Three-quarters of aspirin, 46% of NANSAID and 63% of acetaminophen users were long-term frequent monthly users (1+ years). Seven percent of frequent monthly analgesic users reported using two or more analgesics nearly every day during the month. Frequent analgesic use was most common among older adults and non-Hispanic whites with no differences by gender or education. Use patterns, however, varied by analgesic subgroups. Frequent monthly...Continue Reading

References

May 1, 1991·Annals of Internal Medicine·J M PiperM R Griffin
Oct 26, 1995·The New England Journal of Medicine·W M Lee
Dec 21, 1994·JAMA : the Journal of the American Medical Association·D C Whitcomb, G D Block
Jul 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M SegasothyW M Bennett
Aug 15, 1994·Annals of Internal Medicine·A G JohnsonR O Day
Jul 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G R Matzke
Nov 25, 1996·Archives of Internal Medicine·S Pérez GutthannJ Ris Romeu
Oct 27, 1997·The New England Journal of Medicine·F V SchiødtW M Lee
Jan 16, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Oct 24, 2002·Archives of Internal Medicine·Gary C CurhanMeir J Stampfer
Jan 7, 2003·Pharmacoepidemiology and Drug Safety·Gary C CurhanMeir J Stampfer

❮ Previous
Next ❯

Citations

Jun 28, 2007·Pharmacy World & Science : PWS·Dana Lee HansenEbba Holme Hansen
Jun 3, 2008·Pharmacy World & Science : PWS·Delyth H James, David P French
Mar 12, 2011·International Journal of Clinical Pharmacy·Elsa López-Pintor, Blanca Lumbreras
Aug 31, 2012·American Journal of Epidemiology·Sharon G CurhanGary C Curhan
Apr 26, 2007·Public Health Nursing·Deborah Dillon McDonaldLing Li
Jan 13, 2011·BMJ : British Medical Journal·Sven TrellePeter Jüni
Oct 12, 2013·Annual Review of Medicine·Peter Weeke, Dan M Roden
Jun 19, 2014·Scandinavian Journal of Gastroenterology·Ricardo Anuar DibTomás Navarro-Rodriguez
Jan 15, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Isabelle Le RayMarc Bardou
Jun 22, 2011·Bioorganic & Medicinal Chemistry Letters·Lingaiah NagarapuN J Prameela Subhashini
Nov 6, 2010·Medicina clínica·Arthur Eumann MesasMarcos Aparecido Sarria Cabrera
Jul 14, 2010·The American Journal of Geriatric Pharmacotherapy·Niina PokelaSirpa Hartikainen
Apr 2, 2013·Journal of Strength and Conditioning Research·Christi B BrewerDwight E Waddell
Mar 29, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lawrence Y AgodoaPaul W Eggers
Jan 8, 2008·Seminars in Arthritis and Rheumatism·Loren LaineMarc Hochberg
Oct 6, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jay L GoldsteinBarbara Hunt
Dec 6, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Gary D Klasser, Reny de Leeuw
Jan 1, 2009·Pharmacoepidemiology and Drug Safety·Mary WillyJudy Staffa
Oct 30, 2007·British Journal of Pharmacology·E SelgS-E Dahlén
Jul 19, 2012·Arthritis Care & Research·Robert A OvermanChad L Deal
Apr 17, 2012·International Journal of Cancer. Journal International Du Cancer·Dalsu BarisDebra T Silverman
Jul 29, 2011·Pharmacoepidemiology and Drug Safety·Chenghui Li, Bradley C Martin
Feb 5, 2011·Pharmacoepidemiology and Drug Safety·Angelika D ManthripragadaMary E Willy
Jun 1, 2013·Pharmacoepidemiology and Drug Safety·Yingjun ZhouAndrew N Freedman
Aug 26, 2011·Globalization and Health·Catherine Olivier, Bryn Williams-Jones
Dec 15, 2016·Drug and Chemical Toxicology·Otto KučeraZuzana Červinková
Sep 18, 2013·European Journal of Preventive Cardiology·Annemieke Floor-SchreuderingMarcel L Bouvy
Jan 27, 2009·Revista de saúde pública·Ozlem OzkanMehmet Domac
Dec 12, 2012·Journal of Health Psychology·Lisa L Pineles, Rick Parente
Jun 1, 2010·Journal of Patient Safety·Stacey H KovacMorris Weinberger
Jul 28, 2020·Pharmacoepidemiology and Drug Safety·Alexandra G HopkinsGary A Smith
Sep 27, 2018·Metabolites·Kristine K DennisVictoria L Stevens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.